SCHEMBL8436723

SCHEMBL8436723

O=C1c2ccccc2C(=O)N1CCc1ccsc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.57
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA4 P22748 1/20 0.51
CA9 Q16790 1/20 0.51
ALDH1A1 P00352 5/20 0.50
MAPT P10636 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
GAA P10253 2/20 0.50
RAB9A P51151 2/20 0.50
KDM4E B2RXH2 1/20 0.50
PKM P14618 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
POLB P06746 2/20 0.48
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
HSD17B10 Q99714 2/20 0.47
GLS O94925 1/20 0.47
LMNA P02545 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11461602 0.89 TDP1 (0.65) L3MBTL1TDP1
SCHEMBL9840603 0.83 CASP3 (0.54) CASP3CA1CA2CA9ALDH1A1
SCHEMBL1142116 0.78 CASP3 (0.86) CASP3CA1CA2CA4CA9
SCHEMBL29724090 0.78 CASP3 (0.86) CASP3CA1CA2CA4CA9
SCHEMBL22995827 0.77 CA9 (0.59) CA1CA2CA9ALDH1A1MAPT
SCHEMBL18074272 0.74 CASP3 (0.67) CASP3CA1CA2CA4CA9
SCHEMBL17525592 0.73 TAAR1 (0.43) CA1CA2CA4CA9ALDH1A1
SCHEMBL6699936 0.73 GLS (0.71) CASP3CA9MAPTSMN1; SMN2RAB9A
SCHEMBL10837643 0.73 RPS6KA2 (0.44) ALDH1A1MAPTSMN1; SMN2POLBKMT2A
SCHEMBL3175301 0.72 CASP3 (0.65) CASP3CA1CA2CA4CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5998433-A THERAPY FOR HYPERLIPIDEMIA; ATHEROSCLEROSIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-12-07 US disclosed
CN-1160403-A Substd. heterobicyclic alkyl amines and their use as squalene oxide cyclase inhibitors TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1997-09-24 CN disclosed
EP-0785939-A1 SUBSTITUTED HETEROBICYCLIC ALKYL AMINES AND THEIR USE AS SQUALENE OXIDE CYCLASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 1997-07-30 EP disclosed
WO-1996011201-A1 SUBSTITUTED HETEROBICYCLIC ALKYL AMINES AND THEIR USE AS SQUALENE OXIDE CYCLASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-04-18 WO disclosed